Target intelligence / Profile preview

MicroRNA-548x (miR-548x)

Target
miR-548x
Molecular classification
MicroRNA, Non-coding RNA, Regulatory RNA
01

Overview

MicroRNA-548x is a member of the primate-specific miR-548 family of non-coding RNAs, functioning primarily as a regulatory microRNA involved in post-transcriptional control of gene expression[2][3]. miR-548x directly targets multiple components of the PI3K/AKT/mTOR pathway, thereby suppressing growth and proliferation of human glioblastoma cell lines when overexpressed[2]. Downregulation or loss of miR-548x activity is associated with increased cell proliferation and may contribute to tumorigenesis. The miR-548 family is large and generally considered poorly conserved, but members have been implicated in both tumor suppressor and promoter activities in different cancers, with miR-548x showing evidence of tumor-suppressive effects specifically through modulation of growth-regulatory signaling cascades[2][3]. The molecule is under investigation as a potential biomarker and therapeutic agent, particularly for glioblastoma and possibly other cancers.

Other names
hsa-mir-548xMIR548XmiRNA-548x
02

Mechanism of action

miR-548x acts as a tumor suppressor by directly downregulating several cancer-associated mRNAs involved in the PI3K/AKT/mTOR signaling pathway, including: - PI3KCB - AKT1 - mTOR - Rheb - CREB1 This downregulation results in impaired cell proliferation and cell cycle progression in cancer cells[2].

03

Biological functions

Regulation of gene expression at the post-transcriptional levelCell proliferationCell cycle progressionSuppression of cell viabilityColony formation inhibition
04

Disease associations

Cancer (notably glioblastoma and other tumors)Tumor suppression
05

Safety considerations

Delivery: microRNAs such as miR-548x face significant challenges in therapeutic delivery, including stability, tissue- and cell-specific targeting, and minimizing off-target effects.Off-target gene regulation: Like other miRNAs, unintended repression of non-target mRNAs is possible, which may cause toxicities or unpredictable biological effects.
06

Biomarkers

Tumor proliferation statusDisease progression (especially in glioblastoma)Potential therapeutic response (preclinically)

Beyond the preview

Go deeper on MicroRNA-548x (miR-548x).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MicroRNA-548x (miR-548x).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call